SCHEMBL4906794

SCHEMBL4906794

CCN(Sc1nc(-c2ccccc2)cs1)S(=O)(=O)c1ccc(C)c(C(=O)O)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.42
RAB9A P51151 4/20 0.42
GFER P55789 2/20 0.42
TDP1 Q9NUW8 1/20 0.42
LMNA P02545 2/20 0.41
ALDH1A1 P00352 3/20 0.40
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
MAPT P10636 3/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
HTR1A P08908 1/20 0.39
HTR2A P28223 1/20 0.39
HTR7 P34969 1/20 0.39
RORC P51449 1/20 0.39
HPGD P15428 2/20 0.38
ALOX15 P16050 1/20 0.38
HSD17B10 Q99714 1/20 0.38
PHGDH O43175 1/20 0.38
MAPK1 P28482 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4902449 0.91 TSHR (0.44) NPC1RAB9AGFERTDP1LMNA
SCHEMBL4905500 0.90 NPC1 (0.41) NPC1RAB9AGFERTDP1LMNA
SCHEMBL4901805 0.83 TSHR (0.44) NPC1RAB9AGFERTDP1LMNA
SCHEMBL4894579 0.82 NPC1 (0.41) NPC1RAB9ALMNAALDH1A1MEN1
SCHEMBL4906179 0.82 MEN1 (0.44) NPC1RAB9AGFERLMNAALDH1A1
SCHEMBL4899232 0.77 GRK6 (0.42) LMNAALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL4906791 0.76 LMNA (0.53) NPC1RAB9ATDP1LMNAALDH1A1
SCHEMBL4904276 0.76 PPARA (0.46)
SCHEMBL4906202 0.74 RAB9A (0.44) NPC1RAB9ALMNAALDH1A1MEN1
SCHEMBL4903896 0.73 LMNA (0.46) LMNAALDH1A1SMN1; SMN2HPGDALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD NPC1 59/4885RAB9A 2271/4885GFER 3619/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD NPC1 59/4885RAB9A 2271/4885GFER 3619/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.